Turkish clinics commonly treat congestive heart failure, ischemic heart disease, and post-myocardial infarction damage using regenerative stem cell therapies. Specialized centers in Istanbul and Antalya utilize mesenchymal stem cells and endothelial progenitor cells to repair scarred cardiac tissue and stimulate new blood vessel growth.
- Congestive heart failure: MSC injections target weakened muscle to reduce symptoms like shortness of breath.
- Ischemic heart disease: Progenitor cells promote angiogenesis to improve blood flow in blocked arteries.
- Post-infarction repair: Therapy mitigates scar tissue formation following a major heart attack event.
- Dilated cardiomyopathy: Treatments focus on strengthening and repairing the heart's enlarged left ventricle.
Bookimed Expert Insight: While many clinics offer intravenous delivery, data from top-tier facilities like Liv Hospital Ulus shows a preference for intracoronary catheter delivery for cardiac cases. This direct approach ensures higher cell retention in the damaged myocardium compared to systemic IV infusions. Patients should prioritize doctors with international training, such as Prof. Dr. Hakan Ucar, who brings Mayo Clinic expertise to complex interventional cardiology.
Patient Consensus: Many patients with post-heart attack scarring seek these treatments to improve their ejection fraction. They often emphasize the importance of requesting formal before-and-after echocardiogram reports to verify functional heart muscle recovery.